Today was another trading day bare of major economic data. Shares were all over the place today with the indexes not giving any clear direction at any point of the day. It was not until right before the close that you had a real feel for whether we would close up or down today.

Here are the unofficial closing bell levels:

Dow 9,874.31 -11.49 (-0.12%)
S&P 500 1,073.56 -2.63 (-0.24%)
Nasdaq 2,140.22 +1.08 (0.05%)

Top Analyst Upgrades
Top Analyst Downgrades
Top Stock Rumors
Day Trader Alerts

Here are some highlights from last week's earnings coverage from BloggingStocks:

• Amgen Inc. (NASDAQ: AMGN) reported strong Q2 earnings thought revenue fell but beat analysts' estimates.
• Colgate-Palmolive Co. (NYSE: CL) beat Q2 earnings estimates but revenue suffered from currency effects.
• Dow Chemical Co. (NYSE: DOW) reported a drop in Q2 revenue and a net loss on restructuring charges.
• Eastman Kodak Co. (NYSE: EK) posted a deeper-than-expected Q2 net loss as sales plunged.
• Exxon Mobil Corp. (NYSE: XOM) reported its lowest quarterly profit in years, well short of expectations.

ITT Corp (NYSE: ITT - option chain) shares are rising today after the company reported earnings this morning, posting a second-quarter profit of $201.4 million or $1.10 per share, beating analysts' estimates of 80 cents per share. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on ITT.

ITT opened this morning at $49.67. So far today the stock has hit a low of $49.25 and a high of $51.74. As of 11:40, ITT is trading at $49.80 up $1.53 (3.2%). The chart for ITT looks bullish and S&P gives ITT a positive 4 STARS (out of 5) buy ranking.

Analyst upgrades:

• Friedman Billings upgraded LSI Corp (NYSE: LSI) to Outperform from Market Perform as it believes the risk/reward is attractive at current levels as the company's near-term business trends are stabilizing. The firm maintains a $4 target on the stock.
  
• Merriman upgraded shares of Medarex (NASDAQ: MEDX) to Neutral from Sell on valuation following the stock's 40% decline year-to-date.
  
• Morgan Stanley upgraded ITT Educational (NYSE: ESI) to Overweight from Equal Weight. The firm believes valuation appropriately discounts risks from its internal lending program.
• Noble (NYSE: NE) was upgraded to Buy from Neutral at Goldman and added to the Conviction Buy List.
  
• Energizer (NYSE: ENR) was raised to Neutral from Sell at UBS.
  
• Arch Chemicals (NYSE: ARJ) was upgraded at KeyBanc to Hold from Underweight.

If you've been watching earnings this past week, or if you read last week's Week in Preview, then this coming week may leave you feeling a bit like Bill Murray in Groundhog's Day. That is, again analysts surveyed by Thomson Reuters expect earnings declines to be more frequent and deeper than earnings gains.

Motorola Inc. (NYSE: MOT), Dow Chemical Co. (NYSE: DOW), Anadarko Petroleum Corp. (NYSE: APC), IAC Interactivecorp (NASDAQ: IACI), Moody's Corp. (NYSE: MCO), Elizabeth Arden Inc. (NASDAQ: RDEN), Devon Energy Corp. (NYSE: DVN), Diebold Inc. (NYSE: DBD), Tyco International Ltd. (NYSE: TYC), United Parcel Service (NYSE: UPS), Cisco Systems Inc. (NASDAQ: CSCO), Polo Ralph Lauren Corp. (NYSE: RL), ITT Corp. (NYSE: ITT), and Walt Disney Co. (NYSE: DIS) are scheduled to report quarterly results this week, and they're all expected to report double-digit declines in earnings.

But again this week, let's take a look who Wall Street feels may have done well in the past quarter.

TheStreet.com's Jim Cramer says the economics are still dire, but stocks aren't even flinching on huge warnings.

Preannouncement after preannouncement after preannouncement. Yawn after yawn after yawn.

I've never seen anything like it. Worst ever. But, did anyone really think Ingersoll Rand (NYSE: IR) (Cramer's Take), cut in half here, would make the quarter? How about Nucor (NYSE: NUE) (Cramer's Take)? Stanley Works (NYSE: SWK) (Cramer's Take)? ITT (NYSE: ITT) (Cramer's Take)? Eaton (NYSE: ETN) (Cramer's Take)? Pentair (NYSE: PNR) (Cramer's Take)? I figured they would all miss. I bet the ones that preannounced last night hardly go down. Why should they? ITT's up nicely. Eaton's unchanged. Not even glancing blows. Nucor's up 10! Ten from a preannouncement.

Most glaring: the 10% miss by Joy Global (NASDAQ: JOYG) (Cramer's Take) with the almost 15% rally! Now that's gigantic.

That's why people feel better about this tape. In the end of that big run up, stocks failed to react to even the biggest beats. Now they fail to react to the biggest misses.

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• Bear Stearns Cos. Inc. (NYSE: BSC) reported a profit that missed expectations by a penny.
• Caterpillar Inc. (NYSE: CAT) posted higher profits in the first quarter, boosted by global gains.
• Charles Schwab Corp. (NASDAQ: SCHW) first-quarter earnings were in line with expectations.
• Citigroup Inc. (NYSE: C) posted a bigger-than-expected loss on further write-downs.
• Crocs Inc. (NASDAQ: CROX) lowered first-quarter guidance led the stock to a new 52-week low.
• Eaton Corp. (NYSE: ETN) beat first-quarter estimates due to strong demand overseas.
• Gilead Sciences Inc. (NASDAQ: GILD) posted better-than-expected first-quarter earnings.
• ITT Corp. (NYSE: ITT) raised its first-quarter and full-year earnings guidance.
• Johnson & Johnson (NYSE: JNJ) reported better-than-expected first-quarter earnings.
• JPMorgan Chase & Co. (NYSE: JPM) beat expectations though first-quarter profits fell
• Merrill Lynch & Co. (NYSE: MER) posted a bigger-than-expected first-quarter loss due to write-downs.
• TD Ameritrade Holding Corp. (NASDAQ: AMTD) second-quarter EPS rose 35%, but revenue fell.
• U.S. Bancorp (NYSE: USB) beat first-quarter earnings expectations thought profits slipped.
• Wachovia Corp. (NYSE: WB) posted its first quarterly loss since 2001 and cut its dividend.
• Washington Mutual Inc. (NYSE: WM) swung to a first-quarter loss of more than $1 billion.
• Wells Fargo & Co. (NYSE: WFC) beat expectations though first-quarter profits fell.

MOST NOTEWORTHY: SLM Corp, Tempur Pedic and ITT Corp were today's noteworthy downgrades:

• Morgan Stanley downgraded SLM Corp. (NYSE: SLM) to Underweight from Equal Weight citing the impact on earnings from reduced government subsidies and disrupted capital markets.
  
• Tempur Pedic (NYSE: TPX) was cut to Neutral from Overweight at JP Morgan citing the consumer slowdown and increased competition.
  
• Credit Suisse downgraded ITT Corp. (NYSE: ITT) to Neutral from Outperform citing the surprised management changes announced last night.

OTHER DOWNGRADES:

• Cowen downgraded TechTarget (NASDAQ: TTGT) to Neutral from Outperform.
  
• Merriman lowered Jamba (NASDAQ: JMBA) to Neutral from Buy.
  
• LSI Corp. (NYSE: LSI) was downgraded at Merrill to Neutral from Buy.

ITT Corp. (NYSE: ITT) shares are trading higher after the company announced this morning it expects to beat previously issued first-quarter and full-year profit outlook. ITT predicted first quarter earnings of 80 cents to 82 cents per share, and between $3.80 and $3.95 per share in 2008. Analysts forecast first-quarter earnings of 81 cents per share and full-year earnings of $3.93 per share. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on ITT.

After hitting a one-year high of $73.44 in July, the stock hit a one-year low of $50.94 in March. ITT opened this morning at $57.95. So far today the stock has hit a low of $56.84 and a high of $59.25. As of 12:15, ITT is trading at $57.26, up $0.81 (1.4%). The chart for ITT is bearish but improving while S&P gives ITT a positive 4 STARS (out of 5) buy rating.

For a bullish hedged play on this stock, I would consider a May bull-put credit spread below the $50 range. A bull-put credit spread is an options position that combines the purchase and sale of put options to hedge risk in case the stock doesn't do what you think but still leverage nice returns. For this particular trade, we will make a 7.5% return in just one month as long as ITT is above $50 at May expiration. ITT would have to fall by more than 12% before we would start to lose money. Learn more about this type of trade here.

"Water is the sleeper investment of the decade," says Jim Powell. "Although the world is focused on energy, clean water is in far shorter supply in many regions. That's even true in many parts of the U.S."

The editor of Growth Stock Alert suggests, "A great deal of money will be made by today's earlybird investors who buy strategic water stocks." Here are his favorites in the sector.

"Unlike oil, there is no substitute for water. Some investors mistakenly think that water is a low value commodity that's not likely to deliver good profits. What the critics fail to consider is the equipment needed to
obtain, purify, transport and recycle water is very expensive.

"Calgon Carbon (NYSE: CCC) is my first choice in a water stock. The company is the world's largest supplier of
granulated activated carbon, the principal purification agent for water. The company also supplies complete treatment systems for municipalities and private organizations.

"The company has 16 operating centers and 23 sales and service offices around the world. A few years ago

, the company expanded its purification business to include industrial liquids and gasses. Rising concerns about greenhouse emissions and other pollutants are giving Calgon Carbon another boost.

"I also recommend ITT Corporation (NYSE: ITT), the world's leading supplier of systems that move and purify
water. The company's treatment equipment is sold throughout the world under the Sanitaire, Aquious and WEDECO brands.

MOST NOTEWORTHY: EDO Corp, General Motors, Cameron, Getty Images and Micrus Endovascular were today's noteworthy downgrades:

• EDO Corporation (NYSE: EDO) was downgraded to Neutral from Outperform at Credit Suisse following the acquisition by ITT Corporation (NYSE: ITT). Shares were also downgraded to Market Weight from Overweight at Thomas Weisel and to Hold from Buy at B&T Capital.
  
• Goldman downgraded shares of General Motors Corporation (NYSE: GM) to Neutral from Buy to reflect risk to the company's international and the slowing U.S. economy. Further, Goldman believes expectations for a deal over healthcare costs with unions are now priced into the stock.
  
• Wachovia downgraded Cameron International (NYSE: CAM) to Market Perform from Outperform on valuation.
  
• Kaufman Bros. downgraded shares of Getty Images Inc (NYSE: GYI) to Sell from Hold to reflect reduced expectations following the company's announced price reductions.
  
• CIBC downgraded shares of Micrus Endovascular Corporation (NASDAQ: MEND) to Sector Performer from Outperformer following the company's lowered guidance..

OTHER DOWNGRADES:

• BB&T downgraded Champion Enterprises (NYSE: CHB) and Palm Harbor Homes (NASDAQ: PHHM) to Hold from Buy.
  
• Stifel downgraded HCP Inc (NYSE: HCP) and Medical Properties Trust Inc (NYSE: MPW) to Hold from Buy.
  
• Goldman downgraded E-Trade Financial Corporation (NASDAQ: ETFC) to Neutral from Buy.
  
• Kellwood Company (NYSE: KWD) was downgraded to Neutral from Buy at Broadpoint.

According to the Sunday New York Times, conglomerates are back. Companies like ITT Corp. (NYSE: ITT) and Textron Inc. (NYSE: TXT) are trading near multi-year highs. William Holstein writes:

To some extent, the new conglomerates have simply become lucky. They are riding a global infrastructure spending boom for airports and airlines, power systems, waste water and environmental projects, and hospitals and health care systems, not to mention record government spending on military projects and security surveillance. Their ability to assemble product offerings from different industries is a source of strength, they say.

While I'd be extremely skeptical if someone referred to the recent strength of conglomerates as some sort of new paradigm, it really may be different this time. The conglomerate boom of the 1960s and 1970s ended in disaster for many of the high-fliers, but changes have been made. Private equity firms have employed a conglomerate-like model to generate huge returns for their investors, and smarter management and more competent deal-making is leading to better-crafted hodgepodges of divergent businesses.

Honeywell International (NYSE: HON) CEO David Cote is also quoted in the Times piece: "When you look back at the history, the companies were put together without any real integration. They were really just holding companies. They didn't try to do anything to make the businesses better."

The old-time model of hyping the stock of a conglomerate and using it to acquire companies at a lower price/earnings multiple is no longer in vogue, mercifully.

For an interesting, although not entirely enjoyable, look at the history of the conglomerate business model, pick up a copy of The Rise and Fall of the Conglomerate Kings by Robert Sobel.

MOST NOTEWORTHY: Heelys (HLYS), Audible (ADBL) and Response Genetics (RGDX) were today's most noteworthy initiations:

• Baird believes Heelys (NYSE: HLYS) is poised to report strong results through FY07, which is not reflected in current valuation, and started shares with an Outperform rating and $47 target.

• JMP Securities believes a growing number of consumers will opt to acquire books and physical CD audio books digitally over the internet and started shares of Audible (NASDAQ: ADBL) with an Outperform rating and $12.50 target.

• Caris believes Response Genetics' (NASDAQ: RGDX) diagnostics opportunity may represent a significant long-term growth driver and initiated shares with a Buy rating and $7.50 target...

OTHER INITIATIONS:

• JP Morgan initiated DeVry (NYSE: DV), Corinthian Colleges (NASDAQ: COCO) and Strayer Education (NASDAQ: STRA) with Overweight ratings, ITT Educational Service (NYSE: ESI), Apollo Group (NASDAQ: APOL) and Career Education (NASDAQ: CECO) with Neutral ratings and Universal Technical Institute (NYSE: UTI) with an Underweight rating.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

MOST NOTEWORTHY: Select railroads were popular initiations today:

• Morgan Keegan started shares of Burlington Northern Santa Fe Corp (NYSE: BNI) with an Outperform rating and believes the stock should trade at a premium to Class 1 railroad peers, as the company consistently ranks above its peers in terms of operating ratio and return on invested capital.
  
• Morgan Keegan believes Kansas City Southern (NYSE: KSU) de Mexico provides KSU a tremendous growth opportunity, starting shares with an Outperform rating.
  
• Morgan Keegan also believes Norfolk Southern Corp (NYSE: NSC) is undervalued, despite having some of the best operating metrics in the industry, initiating shares with an Outperform rating.
  
• Union Pacific Corp (NYSE: UNP) was started with an Outperform rating as Morgan Keegan believes earnings estimates and management guidance may be conservative.
  
• Finally, CSX Corp (NYSE: CSX) was initiated with a Market Perform rating at Morgan Keegan as the firm believes there is more risk to the current share price than the potential upside...
  

OTHER INITIATIONS:

• Citigroup started Gaylord Entertainment Co (NYSE: GET) with a Buy rating and $68 target.
  
• Morgan Joseph initiated shares of Jakks Pacific, Inc (NASDAQ: JAKK) with a Buy rating.
  
• ITT Corp (NYSE: ITT) was given an Equal Weight rating by Morgan Stanley.
  
• Banc of America started Healthways, Inc (NASDAQ: HWAY) with a Buy rating and Matria Healthcare, Inc (NASDAQ: MATR) with a Neutral rating.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

On today's STOP TRADING! segment on CNBC, Jim Cramer was discussing buying shares to make money rather than to make a political statement. Cramer would buy Schlumberger Limited (ADR) (NYSE:SLB) regardless of what it does in Sudan, and he won't discuss Darfur.

On ITT Corp. (NYSE:ITT) Cramer thinks the $100 break-up value from Merrill Lynch made a lot of sense. On Vonage Holdings Corp.(NYSE:VG) Cramer is still very negative and may be worst stock of the new century. He laughed that it claimed a win in the patent case because some patents were not found to be guilty.